Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, encompassing a range of conditions caused by lipid deposition within liver cells, and is also associated with obesity and metabolic diseases. Here, we investigated the protective effects of diphlorethohydroxycarmal...
Main Authors: | Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/18/9/475 |
Similar Items
-
Indole-4-carboxaldehyde Isolated from Seaweed, <i>Sargassum thunbergii</i>, Attenuates Methylglyoxal-Induced Hepatic Inflammation
by: Seon-Heui Cha, et al.
Published: (2019-08-01) -
Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis
by: Qiongyu Lu, et al.
Published: (2023-04-01) -
5-Bromoprotocatechualdehyde Combats against Palmitate Toxicity by Inhibiting Parkin Degradation and Reducing ROS-Induced Mitochondrial Damage in Pancreatic β-Cells
by: Seon-Heui Cha, et al.
Published: (2021-02-01) -
The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway
by: Yuhong Huang, et al.
Published: (2024-01-01) -
Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
by: Leanne Hodson, et al.
Published: (2020-07-01)